DRUG GUIDELINE

Furosemide (Frusemide) - Intravenous
SCOPE (Area): Acute, Emergency, ICU, General Wards, Theatre, (Exclude: Paediatrics Seek Advice), Cardiovascular Suite, Coronory Care Unit, Grampians Health At Home (ballarat)
SCOPE (Staff): Medical, Nursing, Pharmacy
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice).


Preamble

See Appendix 1 for full version of this Drug Guideline.


Related Documents

CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPP0544 - Intravenous Drug Administration And Classification List
POL0077 - Medication Management
CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
CPP0662 - Care Of Patients With Heart Failure At Home
SOP0001 - Principles Of Clinical Care


References

Alfred Health (2020, March). Intravenous Frusemide (Furosemide) Drug Guideline. Alfred Health. Retrieved March 21, 2023 from https://app.prompt.org.au/search.
Barwon Health (2018, March). Furosemide (Frusemide) Intravenous Drug Protocol. Barwon Health. Personal communication received February 2019.
CRC Press Taylor and Francis Group. (2022). Renal Drug Database. Retrieved May 24, 2022.
Khan, D., Knowles, S., Shear, N. (2019) Sulfonamide Hypersensitivity: Fact and Fiction. The Journal of Allergy and Clinical Immunology: In Practice, 7 (7), 2116-2123. https://doi.org/10.1016/j.jaip.2019.05.034
MIMS Online. (2022). MIMS Online, Lasix High Dose product information. Retrieved May 24, 2022.
Rossi, S. (2022). Australian Medicines Handbook. Retrieved May 24, 2022.
The Society of Hospital Pharmacists of Australia. (2022). Australian Injectable Drugs Handbook (8th ed.). Retrieved May 24, 2022.
Therapeutic Guidelines Limited. (2022). Therapeutic Guidelines. Retrieved May 24, 2022.
Walters Kluwer. (2019) Lexicomp, Furosemide Drug Information. Retrieved December 3rd, 2019.
Walters Kluwer. (2022) UpToDate, Drug Interaction section. Retrieved May 24, 2022.


Appendix

Appendix 1 - Furosemide (Frusemide) - Intravenous



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 03/04/2023
Review Responsibility: Pharmacist - Rotational Date for Review: 30/09/2024
Furosemide (Frusemide) - Intravenous - DRG0009 - Version: 8 - (Generated On: 19-07-2025 06:02)